Connection

THOMAS COOPER to RNA Precursors

This is a "connection" page, showing publications THOMAS COOPER has written about RNA Precursors.
Connection Strength

3.562
  1. In Brief: (mis)splicing in disease. J Pathol. 2014 May; 233(1):1-3.
    View in: PubMed
    Score: 0.444
  2. Pre-mRNA splicing in disease and therapeutics. Trends Mol Med. 2012 Aug; 18(8):472-82.
    View in: PubMed
    Score: 0.392
  3. Chemical reversal of the RNA gain of function in myotonic dystrophy. Proc Natl Acad Sci U S A. 2009 Nov 03; 106(44):18433-4.
    View in: PubMed
    Score: 0.325
  4. CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA. Nucleic Acids Res. 2009 Jul; 37(13):4275-86.
    View in: PubMed
    Score: 0.315
  5. Alternative splicing in disease. Adv Exp Med Biol. 2007; 623:212-23.
    View in: PubMed
    Score: 0.267
  6. Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing. Biotechniques. 2006 Aug; 41(2):177-81.
    View in: PubMed
    Score: 0.259
  7. Dynamic balance between activation and repression regulates pre-mRNA alternative splicing during heart development. Dev Dyn. 2005 Jul; 233(3):783-93.
    View in: PubMed
    Score: 0.241
  8. Pre-mRNA splicing and human disease. Genes Dev. 2003 Feb 15; 17(4):419-37.
    View in: PubMed
    Score: 0.204
  9. Highlights of alternative splicing regulation session: yes, no, maybe--a history of paradigm shifts. Sci STKE. 2001 Oct 23; 2001(105):pe35.
    View in: PubMed
    Score: 0.186
  10. RNA processing and human disease. Cell Mol Life Sci. 2000 Feb; 57(2):235-49.
    View in: PubMed
    Score: 0.165
  11. Defining pre-mRNA cis elements that regulate cell-specific splicing. Methods Mol Biol. 1999; 118:391-403.
    View in: PubMed
    Score: 0.153
  12. The roles of RNA processing in translating genotype to phenotype. Nat Rev Mol Cell Biol. 2017 02; 18(2):102-114.
    View in: PubMed
    Score: 0.132
  13. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol Cell Biol. 1993 Jun; 13(6):3660-74.
    View in: PubMed
    Score: 0.104
  14. Use of minigene systems to dissect alternative splicing elements. Methods. 2005 Dec; 37(4):331-40.
    View in: PubMed
    Score: 0.062
  15. Identification of CELF splicing activation and repression domains in vivo. Nucleic Acids Res. 2005; 33(9):2769-80.
    View in: PubMed
    Score: 0.060
  16. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 2002 Oct 23; 3(11):reviews0008.
    View in: PubMed
    Score: 0.050
  17. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell. 2002 Jul; 10(1):45-53.
    View in: PubMed
    Score: 0.049
  18. Binding of PurH to a muscle-specific splicing enhancer functionally correlates with exon inclusion in vivo. J Biol Chem. 2000 Jul 07; 275(27):20618-26.
    View in: PubMed
    Score: 0.043
  19. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science. 1998 May 01; 280(5364):737-41.
    View in: PubMed
    Score: 0.037
  20. The regulation of splice-site selection, and its role in human disease. Am J Hum Genet. 1997 Aug; 61(2):259-66.
    View in: PubMed
    Score: 0.035
  21. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature. 2015 Sep 17; 525(7569):384-8.
    View in: PubMed
    Score: 0.030
  22. The relative strengths of SR protein-mediated associations of alternative and constitutive exons can influence alternative splicing. J Biol Chem. 1999 Oct 15; 274(42):29838-42.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.